Treatments for spinal muscular atrophy
US6376508B1 · kind B1 · utility
39Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2000 |
| Grant date | Apr 23, 2002 |
| Priority date | — |
| Expiry date | Dec 13, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method of modulating SMN exon 7 expression in a subject by administering a histone deacetylase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.